Max India Ltd · NSE:MAXIND

Max India — Investor Presentation (May 2006)

40 slides from Max India's investor presentation, May 2006

  1. Slide 1: Max India Limited Investor Presentation

    0D[,QGLD/LPLWHG ,QYHVWRU3UHVHQWDWLRQ

  2. Slide 2: Max journey

    0D[± WKHMRXUQH\IURPWR 3KDUPDFHXWLFDOV 3KDUPDFHXWLFDOV *LVW%URFDGHV7KH1HWKHUODQGV (OHFWURQLF (OHFWURQLF 0RWRUROD86$ &RPSRQHQW &RPSRQHQW 'LVWULEXWLRQ 'LVWULEXWLRQ $YQHW,QF86$ +XWFKLVRQ7HOHFRPPXQLFDWLRQ/WG 0RELOH7HOHSKRQ\ 0RELOH7HOHSKRQ\ +XWFKLVRQ +RQJ.RQJ &RPPXQLFDWLRQ &RPPXQLFDWLRQ &206$7 &RPVDW,QYHV

  3. Slide 3: Birth of a new Max

    ± %LUWKRIDQHZ0D[ /LIH,QVXUDQFH ZZZPD[QHZ\RUNOLIHFRP ZZZPD[KHDOWKFDUHFRP +HDOWKFDUH &OLQLFDO5HVHDUFK ZZZQHHPDQPHGLFDOFRP z )URP%%WR%& z )URP,QWHUPHGLDWHVWR&RQVXPHU6HUYLFH %5$1'6 z 1HZEXVLQHVVQDYLJDWRUV.QRZOHGJH6HUYLFH )RFXV z 5HLQYHQWLQJ6WUDWHJLF&KRLFH

  4. Slide 4: Max India - Life... Our Focus

    0D[,QGLD± /LIH«2XU)RFXV 3URWHFWLQJ/LIH WKURXJK /LIH,QVXUDQFH &DULQJIRU/LIH WKURXJK +HDOWKFDUH ,PSURYLQJ/LIH WKURXJK &OLQLFDO5HVHDUFK

  5. Slide 5: Max India

    0D[,QGLD± 0D[ ,QGLD /LPLWHG ZZZPD[LQGLDFRP LV D PXOWLEXVLQHVV FRUSRUDWH GULYHQ E\ WKH VSLULWRI(QWHUSULVHIRFXVHG RQ.QRZOHGJH 3HRSOHDQG 6HUYLFH RULHQWHG EXVLQHVVHV RI /LIH,QVXUDQFH+HDOWKFDUHDQG&OLQLFDO5HVHDUFK0D[DOVRPDLQWDLQVLQWHUHVWVLQ6SHFLDOW\ 3ODVWLF3URGXFWVIRUWKHSDFNDJLQJLQGXVWU\DQG+HDOWKFDUH6WDII

  6. Slide 6: Investment in Core Businesses

    ,QYHVWPHQWLQ&RUH%XVLQHVVHV 860Q 3ODQQHG &XUUHQW(TXLW\ 3HDN(TXLW\ %XVLQHVV RXWOD\IRU ,QYHVWPHQW ,QYHVWPHQW WKHEXVLQHVV E\0D[,QGLD E\0D[,QGLD /LIH,QVXUDQFH +HDOWKFDUH /LIH,QVXUDQFH± 0D[,QGLD¶VVWDNHLV +HDOWKFDUH± 0D[,QGLD¶VVWDNHLV

  7. Slide 7: Healthcare

    i Healthcare Caring for you... fer life Healthcare

  8. Slide 8: Max Healthcare Model

    0D[+HDOWKFDUH0RGHO 35,0$5< 'U0D[൅ 35,0$5< 'U0D[70 &RQVXOW 'U0D[Œ 'U0D[Œ 'U0D[Œ 0D[ ƒ *3)3&RQVXOW 0HGFHQWUHŒ +RVSLWDO ,PSODQW ƒ 6SHFLDOLVWGRFWRUFRQVXOWDWLRQ 'U0D[Œ 'U0D[Œ ƒ 'LDJQRVWLFV;5D\(&* 'U0D[Œ 'U0D[Œ ƒ 3DWKRORJ\&ROOHFWLRQ ƒ 3DWKRORJ\&ROOHFWLRQ 'U0D[Œ 'U0D[Œ 'U0D[Œ 0D[ 'U0D[Œ ƒ )XOOWLPHQXUVHILUV

  9. Slide 9: Max Healthcare - Geographically Focused on the National Capital Region

    0D[+HDOWKFDUH± &XUUHQWO\*HRJUDSKLFDOO\ )RFXVHGRQWKH1DWLRQDO&DSLWDO5HJLRQ 'HOKLDQGVXUURXQGLQJDUHDV ([LVWLQJ0D[+RVSLWDOV 'U0D[&OLQLFV ,PSODQWV 3URSRVHG0D[+RVSLWDOV 7HUWLDU\FDUH+RVSLWDO

  10. Slide 10: Indian Healthcare

    ,QGLDQ+HDOWKFDUH ‡ 2YHUELOOLRQSHRSOHVSUHDGLQWRPDQ\GLIIHUHQWHFRQRPLFFODVVHV ‡ 0RUHWKDQPLOOLRQXSSHU PLGGOHFODVVJURZLQJDWRYHUSHUDQQXPZLWK FRPELQHGDQQXDOLQFRPHRIRYHU 5V &URUHV !ELOOLRQ *RYHUQPHQW 6HOISD\ 0XQLFLSDO %RGLHV +HDOWKH[SHQGLWXUHLQ,QGLDE\IXQGLQJVRXUFHV )RUHLJQ$LG ‡ 7KLVH[SORGHVWKHP\WKWKDWDPDMRU

  11. Slide 11: Advantage India

    $GYDQWDJH,QGLD &RUH&RPSHWHQFLHV ³,QWHUQDWLRQDO&ODVV7UHDWPHQWDW'RPHVWLF&RVWV´ 4XDOLW\ +XJHUHVRXUFHRIKLJKO\WUDLQHGGRFWRUVQXUVHV SDUDPHGLFV &RPIRUW/HYHO 'RFWRUVRI,QGLDQRULJLQUHFRJQL]HGDVDPRQJVWEHVWLQ86$ 8. (QJOLVK/DQJXDJH 9DOXH3URSRVLWLRQ /RZHUGUXJFRVWV 4XDOLW\PHGLFDOVHUYLFHVDWVXEVWDQWLDOO\ORZHUFRVWV [

  12. Slide 12: Current Facilities

    i Healthcare Caring for you... fer life Current Facilities

  13. Slide 13: Current Facilities

    &XUUHQW)DFLOLWLHV 6HFRQGDU\&DUH0D[+RVSLWDOVRSHUDWLRQDODW 3$1&+6+((/3$5. 3,7$0385$ 12,'$ )HEUXDU\ )HEUXDU\ $XJXVW ‡LQSDWLHQWEHGV ‡LQSDWLHQWEHGV ‡LQSDWLHQWEHGV ‡27 ‡27 ‡27 ‡)XOOUDQJHGLDJQRVWLFV ‡)XOOUDQJHGLDJQRVWLFV ‡)XOOUDQJHGLDJQRVWLFV ‡3+3 23' ‡3+3 23' ‡3+3 23'

  14. Slide 14: Current Facilities - Heart & Vascular Institute, Saket

    &XUUHQW)DFLOLWLHV +($57 9$6&8/$5,167,787(± 6$.(7 ‡ SDWLHQWEHGV ‡ 2SHUDWLRQ7KHDWUHV&DUGLDF &DWKHWHUL]DWLRQ/DEV ‡ 7RWDOFRYHUHGDUHDRIDSSUR[VTIW ‡ 3RVW6XUJHU\&ULWLFDO&DUH8QLW ‡ +LJK'HSHQGHQF\8QLW ‡ $SH[&RURQDU\&DUH ‡ $GYDQFHG&RURQDU\&DUH8QLW ‡ ([FOXVLYH ZHOO HTXLSSHG µ2EVHUYDWLRQ %D\¶ DQGµ3RVW&DWK5HFRYH

  15. Slide 15: Current Facilities - Max Hospital Patparganj

    &XUUHQW)DFLOLWLHV 0$;+263,7$/± 3$73$5*$1- %HG+RVSLWDORQO\RQHRILWVNLQGLQ(DVW 'HOKL FRPSUHKHQVLYH ZLWK IXOO UDQJH RI VHUYLFHVLQFOXGH ‡ &DUGLDF&DWKHWHUL]DWLRQ/DE ‡ 1RQLQYDVLYH&DUGLRORJ\ ‡ 0RWKHU &KLOG ‡ 3+3 ‡ 'LDO\VLV ‡ %ORRG%DQN ‡ 7UDXPDWRORJ\ ‡ $OORWKHU6SHFLDOWLHV 2SHUDWLRQDOVLQFH0D\

  16. Slide 16: Current Facilities - Ophthalmology Dental Centre Panchsheel

    &XUUHQW)DFLOLWLHV 237+$/02/2*< '(17$/&(17(5± 3$1&+6+((/ ‡ /DVLN23'DQG'LDJQRVWLFV ‡ 'HQWDO± FKDPEHUV23*DQG/DE ‡ 6XSSRUW6HUYLFHVDQG2IILFHV 1 6 ‡ 7UDLQLQJ&RQIHUHQFHURRP 2SHUDWLRQDO6LQFH1RYHPEHU

  17. Slide 17: Current Status

    &XUUHQW6WDWXV ¾ 2FFXSDQF\ LPSURYLQJDWHDFKRIWKHKHDOWKFDUHIDFLOLW\ ‡ 0D[7HUWLDU\+RVSLWDO6DNHW± )DFLOLW\ODXQFKHGLQ-DQ¶ ‡ 0D[6HFRQGDU\+RVSLWDO3DWSDUJDQM± )DFLOLW\ODXQFKHGLQ0D\¶ ‡ 0D[6HFRQGDU\+RVSLWDO3LWDPSXUD± 3RVWH[SDQVLRQ ‡ 0D[6HFRQGDU\+RVSLWDO1RLGD± 3RVWH[SDQVLRQ ‡ 0D[0HGFHQWUH3DQFKVKHHO± 3RVWH[SDQVL

  18. Slide 18: Max Healthcare - Project Cost & Funding

    0D[+HDOWKFDUH± 3URMHFW&RVW )XQGLQJ 3KDVH z 0D[,QGLD± 3URPRWHUV (TXLW\ &XUUHQW± 0Q )XWXUH± 0Q z :DUEXUJ3LQFXV± 0Q 86PLOOLRQ z 2WKHU)RUHLJQ,QYHVWRUV± 0Q 3URMHFW&RVW 86PLOOLRQ 'HEW z +')&± 0Q z 2WKHU,QGLDQ%DQNVDQG 86PLOOLRQ )LQDQFLDO,QVWLWXWLRQV± 0Q 'HEW± (TXLW\5DWLR

  19. Slide 19: Upcoming Facilities

    i Healthcare Caring for you... fer life Upcoming Facilities

  20. Slide 20: Upcoming Facilities - Max Hospital Saket

    8SFRPLQJ)DFLOLWLHV 0$;+263,7$/± 6$.(7 ‡ EHGV LQFOXGLQJFULWLFDOFDUHEHGV ‡ 7RLQFOXGH ‡ 27V&RQVXOW&KDPEHUV ‡ 7RZHU 6SHFLDOWLHV ± 2UWKR 1HXUR :RPDQ &KLOGDQG0,6 ‡ %UDLQ /DE ILUVW LQ $VLD LQWUD RSHUDWLYH 05, ‡ '6$/DE IRU1HXUR6FLHQFHV ‡ (PHUJHQF\6HUYLFHV ‡ (VWLPDWHG3URMHFW&RVW± 860Q /DXQFKLQ0DUFK

  21. Slide 21: Upcoming Facilities - Hospitals by and around NCR

    8SFRPLQJ)DFLOLWLHV 0$;+263,7$/± *85*$21 ‡ EHG+RVSLWDOZLWK27V ‡ 7RZHU6SHFLDOWLHVWRLQFOXGH ‡ 2EVWHWULFV3DHGLDWULFV *\QDHFRORJ\ LQFO,QIHUWLOLW\ ‡ 1HSKURORJ\ 8URORJ\ ‡ 3ODVWLF 5HFRQVWUXFWLYH6XUJHULHV ‡ *HQHUDO 0LQLPDOO\,QYDVLYHVXUJHULHV ‡ /DXQFKE\'HFHPEHU ‡ 7HUWLDU\FDUHKRVSLWDOVDW6DNHWWREHVFDOHGXSWREHGV

  22. Slide 22: Max Healthcare - Thinking Ahead

    0D[+HDOWKFDUH± 7KLQNLQJ$KHDG 3KDVH± 1DWLRQDO&DSLWDO5HJLRQ5ROORXW z 6WUDWHJLFFKRLFHV 5HILQHPHQWRI&XUUHQW EDVHGRQ 36+ 1&53RUWIROLRDQG − /HDUQLQJVIURP 6HOHFWHG([SDQVLRQ 1&5UROORXW − /HYHUDJLQJWKH 33$ FROOHFWLYH LQWHOOHFWXDO 1'$ ([SDQVLRQ2SSRUWXQLWLHV FDSLWDOLQWKH VHQLRU 1DWLRQDO PDQDJHPHQW 6.7 ( WHDP z

  23. Slide 23: Max Healthcare - Projected Financials

    0D[+HDOWKFDUH± 3URMHFWHG)LQDQFLDOV 5HYHQXH 86 PLOOLRQ )< )< )< )< )< )< )< )< )< )< )< )< (%,7'$ &DVK3URILW 3$7

  24. Slide 24: Medical Clinical Collaboration

    0HGLFDO&OLQLFDO&ROODERUDWLRQ ‡ 0HGLFDO ‡ 1XUVLQJ ‡ 3DUDPHGLFDO $GYDQFHG+HDUW3K\VLFLDQVDQG 8QLYHUVLW\RI1HEUDVND0HGLFDO 6XUJHRQV1HWZRUN1HZ<RUN &HQWHU 810& 7HDP&RPSULVLQJRI ‡ 6FRSH ‡ 'U96XEUDPDQLXQ ± &KDLUPDQ&DUGLR7KRUDFLF6XUJHU\ 7UDLQLQJ /HQQR[+LOO+RVSLWDO1HZ<RUN 5HVHDUFK ‡ 6XUJHRQV (GXFDWLRQ 'U'LGLHU

  25. Slide 25: Life Insurance

    Sux Your Partner for Life Life Insurance

  26. Slide 26: Max New York Life Insurance

    0$;1(:<25./,)(,1685$1&( ¾ -RLQW9HQWXUHEHWZHHQ0D[,QGLD 1HZ<RUN/LIH,QWHUQDWLRQDO ¾ 1</UDQNHGWK LQ)RUWXQHFRPSDQLHVSURYLGHVLQVXUDQFHGRPDLQH[SHUWLVH ¾ 1</LVRQHRIWKHROGHVWPXWXDOOLIHLQVXUDQFHFRPSDQ\LQWKH86 ZLWKRYHU ELOOLRQLQDVVHWVXQGHUPDQDJHPHQW ¾ 0D[ ,QGLD FRQWULEXWHV ORFDO PDUNHW XQGHUVWDQGLQJ DQG PDQDJL

  27. Slide 27: MNYL's Strategy to build a Strong Life Insurance Business

    01</¶66WUDWHJ\WREXLOGD6WURQJ /LIH,QVXUDQFH%XVLQHVV )XOO6XLWHRISURGXFWVZLWKDIRFXVRQSURWHFWLRQ ¾ /RQJ7HQRUSURGXFWV<RXQJFXVWRPHUEDVH ¾ 8QLW/LQNLQSODFHFRQWULEXWHVRIWRWDOVDOHVIRUWKH&RPSDQ\IRUWKHSHULRG-DQ ± 'HF %XLOGEHVWLQFODVVDJHQF\ ¾ 3URGXFWLYLW\RUGHURIPDJQLWXGHKLJKHUWKDQFRPSHWLWLRQ ¾ 0RVWUHSXWHGLQKRXVH

  28. Slide 28: MNYL's Strategy to build a Strong Life Insurance Business

    01</¶66WUDWHJ\WREXLOGD6WURQJ /LIH,QVXUDQFH%XVLQHVV &XUUHQWSDLGXSFDSLWDOEDVHRI0Q 6WURQJTXDOLW\RULHQWDWLRQVWREXVLQHVV ¾ )LUVWOLIHLQVXUHUWREHDZDUGHGWKH,62FHUWLILFDWLRQ ¾ VLJPDSURJUDPXQGHUZD\ ¾ %DODQFHGVFRUHFDUGDSSURDFK ¾ *RRG$XGLW &RPSOLDQFHRULHQWDWLRQ 6WURQJFXVWRPHUWUXVWDQGFUHGLELOLW\ ¾ %DODQFHGLQYHVW

  29. Slide 29: Protection Oriented Longer Tenor Life Insurance

    3URWHFWLRQ2ULHQWHG/RQJHU7HQRU /LIH,QVXUDQFH 7HQXUH $JHRI,QVXUHG 3523257,212) <HDUV <HDUV 352'8&77<3( 32/,&,(6 E\ QXPEHU :+2/(/,)( (1'2:0(17 7(50 '()(55(' $118,7< 021(<%$&. 81,7/,1.(' ($6<7(50 $FWXDULDO3HUVLVWHQF\RIE\3UHPLXP RISRUWIROLRLVSDUWLFLSDWLQJ H[FOXGLQJ UXUDO 01</$YHUDJH 01</$YHUDJH $VRQ'HFVW

  30. Slide 30: Established Ourselves amongst the Leading Agency Sales Force

    (VWDEOLVKHG2XUVHOYHVDPRQJVWWKH /HDGLQJ$JHQF\6DOHV)RUFH $GMXVWHG6LQJOH3UHPLXP 1HZ%XVLQHVV$SU 3UHPLXPSHU$JHQW 'HF $JHQF\ $JHQWV &DVHVSHU$JHQW 860Q 5DQN 5DQN 5DQN ,QWHUPVRIKLJKHVWQHZEXVLQHVVSUHPLXP $JHQF\ 6RXUFH,5'$-RXUQDOPHGLDUHSRUWV/LIH,QVXUDQFHUHSRUWIURP.RWDN6HFXULWLHVDQGWHDPLQSXWV

  31. Slide 31: Our Footprint

    2XU)RRWSULQW 3KDJZDUD 1DYDVKDKDU 3XQMDE 0RJD &KDQGLJDUK 3DWLDOD *XUJDRQ )DULGDEDG %KDWLQGD -DLSXU 'HOKL 1RLGD -RGKSXU /XFNQRZ 6DQJUXU 8GDLSXU 1DVLN /XGKLDQD $KPHGDEDG ,QGRUH 1DJSXU -DODQGKDU %DURGD .RONDWD 5DMNRW $FWXDOFXVWRPHU $PULWVDU 6XUDW $XUDQJDEDG EDVHVSUHDG 0XPEDL 7KDQH RYHUFLWLHV +\GHUDEDG 3

  32. Slide 32: Market Position - Insurance Sales

    0DUNHW3RVLWLRQ± ,QVXUDQFH6DOHV 860Q ,QGLYLGXDO1HZ%XVLQHVV 3ROLFLHV µ 3UHPLXP $SU'HF $SU'HF ,&,&,3UXGHQWLDO %DMDM$OOLDQ] +')&6WDQGDUG/LIH %LUOD6XQ/LIH 0D[1HZ<RUN/LIH 7DWD $,* $YLYD $OO2WKHUV 7RWDO3ULYDWH/LIH,QVXUHUV 06RI3ULYDWH3OD\HUV 6RXUFH,QVXUDQFH5HJXODWRU\ 'HYHORSPHQW$XWKRULW\$GMXVWHGWRLQFOXGHRQO

  33. Slide 33: Max New York Life Insurance Key Business Drivers

    M A X N EW YO R K LIFE IN SU R A N C E Q uarter Ended Year Ended YoY K ey B usiness D rivers U nit D ec-05 D ec-04 D ec-05 D ec-04 G row th a) Sales Value (Annualized firstyear prem ium ) $ Mn 26.9 16.9 95.1 47.6 100% b) Average case size per agent $ 369 301 349 272 28% c) C ase rate per agentper m

  34. Slide 34: Other Businesses

    2WKHU%XVLQHVVHV

  35. Slide 35: Neeman Medical International

    1((0$10(',&$/,17(51$7,21$/ 1HHPDQ 0HGLFDO ,QWHUQDWLRQDO LV D YDOXH DGGHG &OLQLFDO 5HVHDUFK 6HUYLFH 2UJDQL]DWLRQ 1HHPDQ¶V JRDO LV WR SURYLGHKLJKO\FRPSHWHQW*&3,&+FRPSOLDQW,QYHVWLJDWRUVLQ VHYHUDO JHRJUDSKLHV ZKR KDYH DFFHVV WR SDWLHQWV DQG GHGLFDWHG &OLQLFDO 5HVHDUFK &RRUGLQDWRUV 7KLV DOORZV 1HHPDQ WR

  36. Slide 36: Neeman - Expanding Geographies

    1((0$10(',&$/,17(51$7,21$/ 1RUWK$PHULFD ,QGLD (;3$1',1**(2*5$3+,(6 „ $ODEDPD „ VLWHVLQ0DMRU „ 1RUWK&DUROLQD &LWLHV „ 1HZ-HUVH\ „ /DUJHGLYHUVH „ 7H[DV SRSXODWLRQ „ :LVFRQVLQ „ 7LHXSVZLWK „ $UL]RQD KRVSLWDOV „ 3KLODGHOSKLD 6DQ-RVH /DWLQ$PHULFD &RVWD5LFD „ 1LFDUDJXD „ (VWDEOLVKHG „ %UD]LO EUDQGDQG „ $U

  37. Slide 37: Working towards Preferred Service Provider status

    1((0$10(',&$/,17(51$7,21$/ :RUNLQJWRZDUGV3UHIHUUHG6HUYLFH3URYLGHUVWDWXV ‡ 7KURXJK VXVWDLQHG SRVLWLRQLQJ HIIRUWV JHWWLQJ VSRQVRU 3KDUPD FRPSDQLHVWR GLUHFW &52V WR ZRUNRQO\ZLWK1HHPDQ ‡ 5HZRUNLQJ EXVLQHVV PL[ 7RZDUGV GLUHFW VSRQVRU FRPSDQ\ FHQWULF IURP &52 FHQWULF DV RI WRGD\ &RPPLVVLRQLQJRI'DWDEDVH0DQ

  38. Slide 38: Neeman Latin America and Neeman USA

    1((0$10(',&$/,17(51$7,21$/ 1HHPDQ/DWLQ$PHULFD ‡ &XUUHQWO\RSHUDWLQJLQ&RVWD5LFDDQG1LFDUDJXD ‡ ([SDQGVWR%UD]LO$UJHQWLQDDQG&KLOH ‡ :RUNLQJRQSRWHQWLDODOOLDQFHLQ*XDWHPDOD ‡ +DYLQJ\HDUVRI&OLQLFDO5HVHDUFKRSHUDWLRQV ‡ WULDOVFRQGXFWHG$XGLWHGE\86)'$WLPHV 1HHPDQ86$ ‡ /RFDWHGLQVWDWHVDFURVV1RUWK$PHULFD ‡ :RUNLQJZ

  39. Slide 39: Max Specialty Products

    0$;63(&,$/,7<352'8&76 ¾ 6XEVWDQWLDOH[SDQVLRQSODQVDSSURYHGLQ'HFHPEHU ƒ $GGLWLRQRIDQHZ%233ILOPPDQXIDFWXULQJOLQHZLWKDFDSDFLW\RI73$ ƒ $GGLWLRQRIDQHZWKHUPDOODPLQDWLRQILOPOLQHZLWKDFDSDFLW\RI.60 ƒ (VWLPDWHGSURMHFWFRVWRI0Q± 'HEW(TXLW\PL[RI ƒ 0DLQWDLQOHDGHUVKLSSRVLWLRQLQVSHFLDOLW\SODVWLFILOPVVHJPHQW ¾ *HQHUD

  40. Slide 40: Thank You

    7KDQN<RX

Max India — Investor Presentation (May 2006) on 6ix